This inventor holds 1 USPTO granted patent. Top assignee: Acurastem, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Martin Smrcina and PIKfyve Kinase Inhibitors.
Introduction
Martin Smrcina is an inventor based in Pasadena, California. His patent work includes research into compounds that inhibit PIKfyve, an enzyme associated with biological processes relevant to disease.
Latest Patents
Smrcina is associated with one patent, titled “PIKfyve Kinase Inhibitors.” The invention concerns compounds that inhibit phosphatidylinositol-3-phosphate 5-kinase (PIKfyve) and their potential use in treating diseases and disorders associated with PIKfyve. The patent record provided lists 1 patent.
Career Highlights
Smrcina is associated with Acurastem, Inc., a company working in the biotechnology field. His patent reflects research focused on developing potential therapeutic compounds.
Collaborations
The provided information identifies Ronghua Li and Anil Nair as Smrcina’s coworkers. Their names are associated with his professional context, though specific contributions to the patent were not provided.
Conclusion
Martin Smrcina’s patent work centers on PIKfyve-inhibiting compounds and their potential therapeutic applications, connecting his invention to research at Acurastem, Inc.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile